Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Envirotainer Opens New station in Guangzhou, China 2021-11-04 10:39
Kazia Enrols First Patient to EVT801 Phase I Clinical Trial 2021-11-04 08:38
Sensational artemisinin-piperaquine for treatment of COVID-19 in prospect 2021-11-03 22:42
ERT and Bioclinica become Clario, The Leading Technology Solutions Company for Clinical Trial Innovation and Evidence 2021-11-03 21:33
Tabernacle Health Group Launches Revolutionary Immunity Booster! 2021-11-03 10:00
Antengene Granted IND Approval in China for the Phase Ib Study of ATG-008 (Onatasertib) in Combination with ATG-010 (Selinexor) in Patients with Diffuse Large B-Cell Lymphoma 2021-11-02 08:30
Farrer Park Hospital Introduced Actinium-225 PSMA Nuclear Therapy for Advanced Prostate Cancer 2021-11-01 08:15
Everest Medicines Announces Share Repurchase Transaction Details 2021-11-01 08:00
3M Health Care and Thermo Fisher Scientific Collaborate to Increase Process Efficiency and Scalability in Commercial Therapeutic Manufacturing 2021-10-29 15:45
Alphamab Oncology Announces First Patient Dosed in the Pivotal Clinical Study of KN046 for the Treatment of PD-(L)1 Refractory Advanced NSCLC 2021-10-29 09:36
Hanmi Science Consortium Drives Ambitious Project for Worldwide Vaccine Equity 2021-10-29 09:27
ImmunoForge Inc. receives U.S. FDA ODD for PF1801 2021-10-29 05:50
BioVaxys Further Expands Intellectual Property Portfolio in Global Markets 2021-10-28 20:00
Interim report for Q3 2021 : Bactiguard Holding AB (publ) 2021-10-28 15:23
Launch of Seegene's STARlet-AIOS: All-in-One System Fulfills Critical Need for Fully Automated, High-Throughput Real-Time PCR Testing 2021-10-27 23:40
Frontier Biotechnologies' Long-acting Injectable (Aikening(R)), In A Two Drug Regimen, Proves Safe And Effective For Critically Ill Hospitalized AIDS Patients 2021-10-27 22:08
Frontier Biotechnologies' Long-acting Injectable (Aikening(R)), In A Two Drug Regimen, Proves Safe And Effective For Critically Ill Hospitalized AIDS Patients 2021-10-27 22:06
Frontier Biotechnologies' Long-acting Injectable (Aikening(R)), In A Two Drug Regimen, Proves Safe And Effective For Critically Ill Hospitalized AIDS Patients 2021-10-27 22:03
Adagene Establishes Collaboration for Clinical Trial of ADG106 in Combination with Nivolumab in Patients with Non-Small Cell Lung Cancer in Singapore 2021-10-27 20:52
INOVIO Announces Collaboration with Colombia; Memorandum of Understanding Focuses on Protecting Against COVID-19 and Supporting Broader Health Preparedness Initiatives 2021-10-21 20:00
1 101 102 103 104 105 230